ChiCTR1800017010
正在进行
/
/
/
2018-06-26
/
/
Iron deficiency anaemia; Colorectal cancer
為大腸癌病人在手術前給予經靜脈注射鐵質補充劑（Iron isomaltoside）的效能 – 先導隨機對照試驗
為大腸癌病人在手術前給予經靜脈注射鐵質補充劑（Iron isomaltoside）的效能 – 先導隨機對照試驗
為大腸癌病人在手術前給予經靜脈注射鐵質補充劑（Iron isomaltoside）的效能
随机平行对照
其它
1:1 allocation, treatment allocation will be concealed in sealed opaque envelopes
Single-blind: Investigator/research team
Prince of Wales Hospital, Hospital Authority
/
40
/
2018-07-02
1990-01-01
/
1. Age >18 years old with written informed consent; 2. Anaemia defined as: hemoglobin concentration <13g/dL; 3. Laboratory test confirmed iron deficiency: serum ferritin <30mcg/L alone or serum ferritin 30-100mcg/L with TSAT < 20%.；
登录查看1. Pregnancy or lactation; 2. Other known causes of anaemia apart from iron deficiency: untreated B12/folate deficiency, hemolytic disease, hemoglobinopathy/thalassemia, chronic renal failure on dialysis; 3. Presence of iron overload (serum ferritin > 300g/dL or TSAT > 50%); known hemochromatosis; 4. Previous or ongoing iron replacement/use of erythropoietin within 12 weeks before recruitment; 5. Known hypersensitivity towards iron isomaltoside; 6. Significant liver function derangement (AST/ALP exceeding three times upper limit of normal range); 7. Use of preoperative immunosuppressant therapy; 8. Participation in another ongoing interventional clinical trial(s); 9. Patients with less than 3 weeks waiting time to surgery.；
登录查看香港中文大學威爾斯親王醫院麻醉與重症監護部
/
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
